Skip to main content

Table 3 HrHPV prevalence and compliance with follow-up in self-samplers, stratified by age groups

From: Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial

  HrHPV prevalence Compliance with follow-up within (days) Total
   ≤ 30 31–60 61–90  
  N na (%) nb(%) nb(%) nb(%) nb(%)
Age (years)
 30–39 312 49 (15.7) 40 (81.6) 2 (4.1) 2 (4.1) 44 (89.8)
 40–49 397 48 (12.1) 31 (64.6) 9 (18.8) 4 (8.3) 44 (91.7)
 50–64 196 21 (10.7) 11 (52.4) 7 (33.3) 1 (4.8) 19 (90.5)
 Total 905 118 (13.0) 82 (69.5) 18 (15.3) 7 (5.9) 107 (90.7)
  1. N: Number of received self-samples. na: Number of women with a hrHPV-positive self-sample. nb: Number of women with a cervical cytology triage sample
  2. %: Row percentages
\